These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7907109)

  • 1. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion.
    Gorczynski RM; Wojcik D
    J Immunol; 1994 Feb; 152(4):2011-9. PubMed ID: 7907109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.
    Gorczynski RM; Cohen Z; Leung Y; Chen Z
    J Immunol; 1996 Jul; 157(2):574-81. PubMed ID: 8752904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells.
    Gorczynski RM; Kiziroglu F
    Transplantation; 1994 Jul; 58(1):51-8. PubMed ID: 8036708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
    Gorczynski RM; Fu XM; Issekutz T; Cohen Z
    Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells.
    Gorczynski RM
    Immunology; 1994 Jan; 81(1):27-35. PubMed ID: 8132216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immunization.
    Gorczynski RM; Hozumi N; Wolf S; Chen Z
    Transplantation; 1995 Dec; 60(11):1337-41. PubMed ID: 8525531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts.
    Gorczynski RM
    Cell Immunol; 1995 Feb; 160(2):224-31. PubMed ID: 7720084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity for in vivo graft prolongation in gamma delta T cell receptor+ hybridomas derived from mice given portal vein donor-specific preimmunization and skin allografts.
    Gorczynski RM; Chen Z; Zeng H; Fu XM
    J Immunol; 1997 Oct; 159(8):3698-706. PubMed ID: 9378955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
    Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
    J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance.
    Takeuchi T; Lowry RP; Konieczny B
    Transplantation; 1992 Jun; 53(6):1281-94. PubMed ID: 1351322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered patterns of migration of cytokine-producing T lymphocytes in skin-grafted naive or immune mice following in vivo administration of anti-VCAM-1 or -ICAM-1.
    Gorczynski RM; Chung S; Hoang Y; Sullivan B; Chen Z
    Immunology; 1996 Apr; 87(4):573-80. PubMed ID: 8675211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes.
    Gorczynski RM
    Immunol Lett; 1992 Jun; 33(1):67-77. PubMed ID: 1427992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of skin graft rejection in alloimmune mice by anti-VCAM-1:VLA-4 but not anti-ICAM-1:LFA-1 monoclonal antibodies.
    Gorcyznski RM; Chung S; Fu XM; Levy G; Sullivan B; Chen Z
    Transpl Immunol; 1995 Mar; 3(1):55-61. PubMed ID: 7551980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
    Chung SW; Gould B; Zhang R; Hu Y; Levy GA; Gorczynski RM
    Surgery; 1998 Feb; 123(2):171-80. PubMed ID: 9481403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for persistent expression of OX2 as a necessary component of prolonged renal allograft survival following portal vein immunization.
    Gorczynski RM; Chen Z; Kai Y; Lei J
    Clin Immunol; 2000 Oct; 97(1):69-78. PubMed ID: 10998319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.